NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
Back to search
Official data from USPTO
RETINOPEPTIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RETINOPEPTIDE
ST13
US500000097708528Class
1, 3
Filing
97708528
Registration
7424957
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/25/2024
Trademark type
Word
Nice classes
1, 3
Filing date
12/08/2022
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2013-00-00
First use in commerce
2013-00-00
Drawing code
4
Owner type
99
Owner location
Holzminden, DE
Examiner
DINALLO, KEVIN M
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Symrise AG
Representatives
Stephen R. Barrese DILWORTH & BARRESE, LLP
Technical classification
Nice Classes
Class 1Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical raw materialsprotein hydrolysates; Herb extractsother than essential oilsfor use in the manufacture of cosmetics and peptides; Plant extractsother than essential oilsfor use in the manufacture of cosmetics; Raw proteinsoligopeptidesalkyl modified peptidesalkyl terminated oligopeptides for use in the manufacture of cosmetics; Collagen used as a raw ingredient in the manufacture of cosmetics; Starches and amino acids as raw materials for use in the manufacture of cosmetics; Fatty acids for use in the manufacture of cosmetics; Plant extractsother than essential oilsantioxidants for use in the manufacture of cosmetics; Vitamins for use in the manufacture of cosmetics; Maltodextrinyarrow/achillea millefolium extractherb extractsother than essential oilsfor use in the manufacture of cosmetics and beauty products; Peptides for use in the manufacture of cosmetics
Class 3
Cosmetic ingredientscollagenhyaluronic acidemollientsplant and herb extractsother than essential oilssold as an integral component of cosmetic preparations for skin carehair carepersonal carebeauty care
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2024
GNRT
NON-FINAL ACTION E-MAILED
02/23/2024
CNRT
NON-FINAL ACTION WRITTEN
02/23/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/09/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/27/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/27/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/27/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/28/2023
GNRT
NON-FINAL ACTION E-MAILED
09/28/2023
CNRT
NON-FINAL ACTION WRITTEN
09/28/2023
DOCK
ASSIGNED TO EXAMINER
09/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2023
NWAP
NEW APPLICATION ENTERED
12/12/2022
Continuous trademark protection
Get notified about every new filing that threatens RETINOPEPTIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.